Affinity Biosensors, a Santa Barbara-based healthcare diagnostics company, announced April 3 that its flagship LifeScale AST system has received FDA clearance. The company said that the FDA’s approval was a milestone that clears the way for healthcare professionals to begin using an important tool for managing bacteremia by providing antibiotic susceptibility test (AST) results with…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
